1. Home
  2. ESPR vs SBGI Comparison

ESPR vs SBGI Comparison

Compare ESPR & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.89

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Logo Sinclair Inc.

SBGI

Sinclair Inc.

HOLD

Current Price

$15.27

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
SBGI
Founded
2008
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
898.5M
1.1B
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
ESPR
SBGI
Price
$3.89
$15.27
Analyst Decision
Buy
Buy
Analyst Count
6
5
Target Price
$6.67
$21.00
AVG Volume (30 Days)
5.3M
400.8K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
6.55%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$303,802,000.00
$3,337,000,000.00
Revenue This Year
$26.11
N/A
Revenue Next Year
N/A
$10.36
P/E Ratio
N/A
N/A
Revenue Growth
2.83
N/A
52 Week Low
$0.69
$11.89
52 Week High
$4.13
$17.88

Technical Indicators

Market Signals
Indicator
ESPR
SBGI
Relative Strength Index (RSI) 55.97 46.88
Support Level $3.87 $15.09
Resistance Level $4.05 $15.51
Average True Range (ATR) 0.20 0.62
MACD -0.02 -0.12
Stochastic Oscillator 50.00 20.95

Price Performance

Historical Comparison
ESPR
SBGI

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About SBGI Sinclair Inc.

Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.

Share on Social Networks: